EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dopamine D1 Receptor Contributes to Glucocorticoid‐Associated Osteonecrosis of Femoral Head Protection Through the ATF3/CHOP Axis to Inhibit Osteoblastic Apoptosis

Kai Zheng iD, Wenming Li, Tianhao Wang, Gaoran Ge, Wei Zhang, Yi Qin, Wenhao Li, Zebin Wu, Zhen Wang, Gang Rui, Yaozeng Xu, Dechun Geng iD

Advanced Science · 2025

DOI: 10.1002/advs.202502276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Kai Zheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou, 215000, China. Hauptthemen laut MEDLINE: Apoptosis, Glucocorticoids, Receptors, Dopamine D1, Osteoblasts. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Jiangsu Medical Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The nervous system plays a pivotal regulatory role in the maintenance of bone homeostasis, and the protective effects of dopamine and its receptors on bone metabolism are emerging. Despite these protective roles, the functional contribution of dopaminergic signaling, particularly through specific receptor subtypes, remains unexplored in glucocorticoid (GC)‐associated osteonecrosis of the femoral head (ONFH) pathogenesis. Here, the dopamine D1 receptor (DRD1), a G protein‐coupled receptor with few identified bone‐related functions, is identified as a positive regulator of GC‐induced apoptosis. The dopamine levels in the serum of GC‐associated ONFH patients are significantly lower than those in the normal population. The protein and gene expression levels of DRD1 and the number of DRD1‐positive cells are abnormally elevated in the pathological state of GC‐associated ONFH, and DRD1 is expressed in osteoblasts. Overexpression of DRD1 attenuates GC‐induced osteogenic inhibition and apoptosis in vivo and in vitro. Mechanistically, overexpression of DRD1 elevates cAMP levels, activates downstream protein kinase A, and inhibits GC‐induced endoplasmic reticulum stress and apoptosis through the ATF3/CHOP signaling pathway, thus improving bone homeostasis. Importantly, Madopar, an FDA‐approved dopaminergic agent, inhibits GC‐induced osteoblastic apoptosis and ONFH via DRD1. Collectively, this study not only deciphers a previously unrecognized DRD1‐mediated neuro‐osteogenic axis but also repurposes an FDA‐approved drug (Madopar) for precision ONFH management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisGlucocorticoidsReceptors, Dopamine D1OsteoblastsFemur Head NecrosisActivating Transcription Factor 3Transcription Factor CHOPAnimalsHumansMiceSignal TransductionMaleFemale

Stichwörter der Autor:innen

apoptosisdopamine D1 receptorsglucocorticoid‐associated ONFHosteogenesis

Substanzen

GlucocorticoidsReceptors, Dopamine D1Activating Transcription Factor 3Transcription Factor CHOPATF3 protein, humanDDIT3 protein, humanDRD1 protein, human

Autor:innen und Institutionen

  • Department of Orthopedics, The First Affiliated Hospital of Soochow University, Suzhou, 215000, China.
  • Department of Orthopedics, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, China.
  • Department of Orthopedics, Wuxi Ninth People's Hospital Affiliated to Soochow University, Wuxi, 214000, China.
  • Department of Orthopedics, Suzhou Kowloon Hospital Shanghai Jiao Tong University School of Medicine, Suzhou, Jiangsu, 215000, China.

ORCID-Profile: Kai Zheng, Dechun Geng

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Jiangsu Medical Research Project
  • Project of MOE Key Laboratory of Geriatric Diseases and Immunology
  • Program of Suzhou Health Commission
  • National and Local Engineering Laboratory of New Functional Polymer Materials
  • Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
  • Xiamen Municipal Bureau of Science and Technology

Zitieren

APA

Zheng, K., Li, W., Wang, T., Ge, G., Zhang, W., Qin, Y., Li, W., Wu, Z., Wang, Z., Rui, G., Xu, Y., & Geng, D. (2025). Dopamine D1 Receptor Contributes to Glucocorticoid‐Associated Osteonecrosis of Femoral Head Protection Through the ATF3/CHOP Axis to Inhibit Osteoblastic Apoptosis. Advanced Science. https://doi.org/10.1002/advs.202502276

Vancouver

Zheng K, Li W, Wang T, Ge G, Zhang W, Qin Y, et al. Dopamine D1 Receptor Contributes to Glucocorticoid‐Associated Osteonecrosis of Femoral Head Protection Through the ATF3/CHOP Axis to Inhibit Osteoblastic Apoptosis. Advanced Science. 2025. doi:10.1002/advs.202502276

BibTeX
@article{Zheng2025,
  author = {Zheng, Kai and Li, Wenming and Wang, Tianhao and Ge, Gaoran and Zhang, Wei and Qin, Yi and Li, Wenhao and Wu, Zebin and Wang, Zhen and Rui, Gang and Xu, Yaozeng and Geng, Dechun},
  title = {Dopamine D1 Receptor Contributes to Glucocorticoid‐Associated Osteonecrosis of Femoral Head Protection Through the ATF3/CHOP Axis to Inhibit Osteoblastic Apoptosis},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202502276}
}
Kostenlos starten →